JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
Closure for trading window.31-03-2021
31-03-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Financial Results For The Quarter Ended 31 December, 2020.
Financial Results for the quarter ended 31 December, 2020.12-02-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON FEBRUARY 12TH, 2021
We wish to inform you that the Board of Directors of the Company at their meeting held today, (i.e., Friday, the 12th Day of February, 2021), have inter alia, approved and taken on record the followings: 1. Un-Audited Financial Results of the Company for the Quarter and Nine Months ended 31st December, 2020; 2. Limited Review Report for the Quarter and Nine Months ended 31st December, 2020; The meeting was stared at 1200 hours and concluded at 1440 hours.12-02-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2020. This is for your information and records.03-02-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended December 31, 2020
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here20-01-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended 31 December, 2020.08-01-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- NANDITA SINGHDesignation :- Company Secretary and Compliance Officer08-01-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
Closure of Trading Window.04-01-2021
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulations, (Amendments) 2018 For The Half Year Ended 30Th September, 2020.
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed disclosure of Related Party Transaction, in the format specified in the Accounting Standard for the half year ended September 30, 2020. This is for your information and records.07-12-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed herewith disclosure of Related Party Transaction, in the format specified in the Accounting Standard for the half year ended September 30, 2020. This is for your information and records.07-12-2020